首页 | 本学科首页   官方微博 | 高级检索  
     

多聚二磷酸腺苷核糖聚合酶-1通过激活NF-κB途径导致高糖人视网膜血管内皮细胞凋亡
引用本文:卢建民,张珍珍,郑玥,马翔,秦秀虹. 多聚二磷酸腺苷核糖聚合酶-1通过激活NF-κB途径导致高糖人视网膜血管内皮细胞凋亡[J]. 眼科新进展, 2015, 0(2): 111-115. DOI: 10.13389/j.cnki.rao.2015.0030
作者姓名:卢建民  张珍珍  郑玥  马翔  秦秀虹
作者单位:116011 辽宁省大连市,大连医科大学附属第一医院眼科
基金项目:国家自然科学基金资助(编号:81300737)~~
摘    要:目的 探讨多聚二磷酸腺苷核糖聚合酶-1[poly(adenosinediphosphate-ribose)polymeras-1,PARP-1]和核因子-κB(nu-clearfactor-κB,NF-κB)在高糖人视网膜血管内皮细胞(retinalvascularendothelialcells,RVEC)中的相互作用及其在人RVEC中的表达定位及作用机制。方法 体外培养人RVEC及HEK293T细胞,并进行传代,同时构建高糖人RVEC细胞模型。构建PARP-EGFP及Flag-NF-κB质粒,酶切鉴定后转染高糖培养的人RVEC,Westernblot法检测重组质粒表达目的基因的效果,并应用Westernblot法和免疫共沉淀法检测高糖人RVEC中PARP-1和NF-κB的相互作用。PARP-EGFP和Flag-NF-κB质粒共转染人RVEC,激光共聚焦扫描显微镜检测PARP-1和NF-κB在高糖人RVEC中的定位及其相互作用。结果 人RVEC复苏后24h贴壁,细胞呈扁平梭形,3d左右细胞开始融合呈铺路石样,单层生长,铺满瓶底,并可见接触抑制现象。成功构建PARP-EG-FP及Flag-NF-κB质粒,并有效表达目的基因。免疫共沉淀结果显示PARP-1和NF-κB是相互作用的蛋白质,高糖组NF-κBp50的条带比正常对照组明显增粗,并且高糖情况下PARP-1结合NF-κB的量较正常对照组明显增加。激光共聚焦扫描显微镜结果显示PARP和NF-κB均表达于正常的人RVEC的细胞核和核周区域,当受到高浓度葡萄糖影响后,PARP-1和NF-κB均集中表达于细胞核内,尤以NF-κB最显著。结论 PARP-1和NF-κB是相互作用的蛋白质,血糖增高时,PARP-1可能进入细胞核内并结合同时进入细胞核的NF-κB,激活NF-κB信号通路,引起RVEC凋亡,导致DR的发生。

关 键 词:多聚二磷酸腺苷核糖聚合酶-1  核因子-κB  视网膜血管内皮细胞  糖尿病视网膜病变

 Poly ( adenosine diphosphate-ribose) polymerase l leads to apoptosis through activating NF-KB signaling pathway in high glucose cultured retinal vascular endothelial cell
LU Jian-Min;ZHANG Zhen-Zhen;ZHENG Yue;MA Xiang;QIN Xiu-Hong.  Poly ( adenosine diphosphate-ribose) polymerase l leads to apoptosis through activating NF-KB signaling pathway in high glucose cultured retinal vascular endothelial cell[J]. Recent Advances in Ophthalmology, 2015, 0(2): 111-115. DOI: 10.13389/j.cnki.rao.2015.0030
Authors:LU Jian-Min  ZHANG Zhen-Zhen  ZHENG Yue  MA Xiang  QIN Xiu-Hong
Affiliation:Department of Ophthalmology, the First Affiliated Hospital of Dalian Medical University , Dalian 116011, Liaoning Province. China
Abstract:Objective To investigate the interaction of Poly ( adenosine diphosphate-ribose) polymeras-l ( PARP-I ) and nuclear factor kappa B ( NF- KB ) under high glucose stimulation , and the location of PARP-I and NF-KB in human retinal vascular endothelial cells ( RVEC) . Methods RVEC and HEK293T cells were cultured and passaged in vitro.while RVEC cell model in high glucose was also built. PARP-EGFP and Flag-NF-KB plasmids were constructed to transfect human RVEC after restriction endonuclease analysis. The effect of target gene expression of recombinant plasmid was examined by Westem blot method. The interaction of PARP-I and NF-KB in high-glucose-cultured human RVEC was examined by Western blot and co-immunoprecipitation method. PARP-EGFP and Flag-NF-KB plasmids were co-transfected into human RVEC. The location of PARP-I and NF-KB in high-glucose-cultured human RVEC was tested under confocal laser scanrung microscope. Results RVEC were adhered to the dish after recovery of 24 hours and the cells were fusiform and flat. The cells started to converge like paving stone after 3 days, grew as monolayers , covered the bottom . and contact inhibition was seen. PARP-EGFP and Flag-NF-KB plasmids were constructed successfully and expressed the target gene effectively. It was discovered that PARP-I interacted with NF-KB in RVEC by co-immunoprecipitation,and the amounts of NF-KB p50 in high glucose was greater than those in normal cells. While the interaction could be enhanced by highlevel glucose stimulation. The results of confocal laser scanning microscope showed that PARP-I and NF-KB were localized in both the nucleus and perinuclear areas in normal endothelial cells .but they were mainly localized in the nucleus after high-level glucose stimulation , more significantly for NF-KB. Conclusion PARP-I and NF-KB are interacted proteins. PARP-I may activate NF-KB by entering the nucleus when the blood glucose increase.where it combines with NF-KB to lead the RVEC apoptosis related to diabetic retinopathy.
Keywords:Poly ( adenosine diphosphate-ribose ) polymeras-l  nuclear factor kappa B  retinal vascular endothelial cells  diabetic retinopathy
本文献已被 CNKI 等数据库收录!
点击此处可从《眼科新进展》浏览原始摘要信息
点击此处可从《眼科新进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号